FTC Defends Impax Pay-For-Delay Ruling At 5th Circ.
The Federal Trade Commission has urged the Fifth Circuit to reject Impax Laboratories' appeal of an FTC order finding that the company's deal to delay its generic version of an opioid...To view the full article, register now.
Already a subscriber? Click here to view full article